| Member Request | | |
| 135#1h | R&D Support for COVID-19 Treatments | $10,000,000 | $0 |
| Committee Approved | | |
| 135#1h | COVID-19 Drug Research and Development | $5,000,000 | $0 |
| 135#2h | Technical Correction - Nongeneral Fund Update for VIPA | $20,000,000 | $0 |
| 135#3h | Technical Update - VIPA Centers of Excellence (Language Only) |
| Floor Approved | | |
| 135#1h | COVID-19 Drug Research and Development | $5,000,000 | $0 |
| 135#2h | Technical Correction - Nongeneral Fund Update for VIPA | $20,000,000 | $0 |
| 135#3h | Technical Update - VIPA Centers of Excellence (Language Only) |
| Conference Report | | |
| 135#1c | Technical Correction - Nongeneral Fund Update for VIPA | $20,000,000 | $0 |
| 135#2c | VIPA Centers of Excellence (Language Only) |
| 135#3c | COVID-19 Drug Research and Development | $5,000,000 | $0 |